Tag: Patient Safety

FDA: Class I recall of Arrow International’s Arrow-Trerotola PTD

Editor's Note The Food and Drug Administration (FDA) on February 23 identified the recall by Arrow International (Reading, Pennsylvania), a subsidiary of Teleflex Inc, of its Arrow-Trerotola Percutaneous Thrombolytic Device (PTD) as Class I, the most serious. The recall was initiated because of the risk of tip damage during use…

Read More

By: Judy Mathias
February 24, 2022
Share

Study: COVID-19 linked with increased risk of diabetes in youths

Editor's Note According to a study in the Morbidity and Mortality Weekly Report, COVID-19 increases the risk of and may contribute to new-onset diabetes among children and adolescents, JAMA reports.  JAMA’s February 22 article notes that data from previous studies showed an average of 14% of adults hospitalized with COVID-19…

Read More

By: Tarsilla Moura
February 24, 2022
Share

Impact of COVID-19 on hospital-acquired bloodstream infections

Editor's Note This study led by researchers at Ascension Health Care, St Louis, finds that COVID-19 was associated with substantial increases in hospital-acquired bloodstream infections, which were largely attributed to COVID-19 infected patients. A total of 1,417,036 admissions in 69 US hospitals were analyzed before (703,556) and during (713,480) the…

Read More

By: Judy Mathias
February 24, 2022
Share

FDA: Class I recall of Vyaire Medical’s Bellavista Ventilators

Editor's Note The Food and Drug Administration (FDA) on February 17 identified the recall by Vyaire Medical (Mettawa, Illinois) of its Bellavista 1000 and 1000e Series Ventilators as Class I, the most serious. The recall was initiated because of issues with the software version 6.0.1600.0 or higher, after reports of…

Read More

By: Judy Mathias
February 24, 2022
Share

CDC report: US maternal mortality rate higher in 2020

Editor's Note The Centers for Disease Control and Prevention (CDC) on February 23 released the “Maternal Mortality Rates in the United States” report for 2020, after analyzing data from the National Vital Statistics System and calculating mortality rates as the number of maternal deaths per 100,000 live births. The report…

Read More

By: Tarsilla Moura
February 24, 2022
Share

The Joint Commission releases 10 most common sentinel events of 2021

Editor's Note The Joint Commission recently released a Sentinel Event Data summary that includes a 2021 update and the 10 most common sentinel events reported to the accreditation body last year, the February 22 Becker’s Hospital Review reports. Only a small portion of all sentinel events are reported to The…

Read More

By: Tarsilla Moura
February 23, 2022
Share

Effect of public transportation on incidence of COVID-19 in HCWs

Editor's Note In this study from Switzerland, regular use of public transportation by healthcare workers (HCWs) was not found to affect the risk for acquiring COVID-19. Of 376 HCWs analyzed, 225 used public transportation. By group comparison, HCWs using public transportation did not acquire a significantly greater percentage of COVID-19…

Read More

By: Judy Mathias
February 22, 2022
Share

FDA: Class I recall of E25Bio COVID-19 Direct Antigen Rapid Tests

Editor's Note The Food and Drug Administration (FDA) on February 18 identified the recall by E25Bio (Cambridge, Massachusetts) of its COVID-19 Direct Antigen Rapid Tests as Class I, the most serious. The tests are being recalled for several reasons, particularly because they were marketed and distributed in the US without…

Read More

By: Judy Mathias
February 22, 2022
Share

Poll: 23% of HCWs likely to leave profession soon

Editor's Note A USA Today/Ipsos Poll that was released on February 22 and was conducted between February 9 and February 16 found that almost 1 in 4 healthcare workers (HCWs) report they are likely to leave the healthcare field in the near future, Becker’s Hospital Review reports. The poll surveyed…

Read More

By: Tarsilla Moura
February 22, 2022
Share

10-year outcomes of off-pump vs on-pump CABG in Department of Veterans Affairs patients

Editor's Note This multi-center, randomized, clinical trial that compares on-pump coronary artery bypass grafting (CABG) with off-pump CABG finds no advantage for off-pump CABG. A total of 2,203 veterans were randomly assigned to off-pump (1,104) or on-pump (1,099) CABG procedures at 18 VA medical centers, and the veterans were then…

Read More

By: Judy Mathias
February 17, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat